Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis

Chenzhi Jing,Tomas Castro-Dopico,Nathan Richoz,Zewen K. Tuong,John R. Ferdinand,Laurence S. C. Lok,Kevin W. Loudon,Gemma D. Banham,Rebeccah J. Mathews,Zaeem Cader,Susan Fitzpatrick,Kathleen R. Bashant,Mariana J. Kaplan,Arthur Kaser,Randall S. Johnson,Michael P. Murphy,Richard M. Siegel,Menna R. Clatworthy

DOI: https://doi.org/10.1073/pnas.2000943117

IF: 11.1

2020-06-15

Proceedings of the National Academy of Sciences

Abstract:Significance IgG antibodies are a key component of adaptive humoral immunity but can cause organ damage if they bind self-antigen, as occurs in the autoimmune disease systemic lupus erythematosus (SLE). Many of the proinflammatory effects of IgG are mediated by ligating Fcγ receptors (FcγRs) expressed by tissue-resident leukocytes such as macrophages. One of the most serious complications of SLE is kidney inflammation: lupus nephritis. Here we show that IgG ligation of FcγRs on macrophages in the kidney leads to a change in their metabolism, resulting in a switch toward glycolysis. Administration of a glycolysis inhibitor attenuated IgG-associated kidney macrophage activation, proinflammatory cytokine secretion, and kidney inflammation. Therefore, manipulating macrophage metabolism may be a useful therapeutic strategy in lupus nephritis.

multidisciplinary sciences